Cargando…
TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases
Cardiovascular diseases (CVD) are the first cause of mortality in Western countries. CVD include several pathologies such as coronary heart disease, stroke or cerebrovascular accident, congestive heart failure, peripheral arterial disease, and aortic aneurysm, among others. Interaction between membe...
Autor principal: | Blanco-Colio, Luis M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895871/ https://www.ncbi.nlm.nih.gov/pubmed/24478772 http://dx.doi.org/10.3389/fimmu.2014.00003 |
Ejemplares similares
-
TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013) -
TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic
por: Cheng, Emily, et al.
Publicado: (2013) -
A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
por: Méndez-Barbero, Nerea, et al.
Publicado: (2019) -
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges
por: Méndez-Barbero, Nerea, et al.
Publicado: (2020) -
TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction
por: Sato, Shuichi, et al.
Publicado: (2014)